Clinical Trials Policy
Clinical Trials Policy
The International Invention of Scientific Journal (IISJ) adheres to international best practices for the ethical conduct and transparent reporting of clinical research.
1. Registration Requirement
All clinical trials must be registered in a publicly accessible registry before the enrollment of participants.
Acceptable registries include:
-
Other nationally or internationally recognized registries
2. Mandatory Disclosure
-
The trial registration number and the name of the registry must be included in the manuscript, preferably in the Methods section.
-
Manuscripts reporting unregistered trials may be rejected without peer review.
3. Ethical Standards
-
All clinical studies must comply with the Declaration of Helsinki and obtain approval from relevant institutional review boards (IRB) or ethics committees.
-
Authors must obtain written informed consent from all participants (or guardians, where applicable).
-
Any identifiable participant information must only be published with explicit consent.
4. Transparency and Data Availability
-
Authors are encouraged to provide access to anonymized trial data to support reproducibility and scientific integrity.